The use of melatonin for the treatment of insomnia

NeuroSignals

Volumn 8, Issue 1-2, 1999, Pages 84-89

  Zisapel, Nava ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Circadian rhythms; Insomnia; Melatonin; Sleep; Therapy

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MELATONIN;

CIRCADIAN RHYTHM; HUMAN; INSOMNIA; JET LAG; NIGHT SLEEP; PINEAL BODY; REVIEW; SENESCENCE; SLEEP DISORDER; SLEEP WAKING CYCLE;

AGED; AGING; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CIRCADIAN RHYTHM; HUMANS; MELATONIN; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0033032485     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014574     Document Type: Article

References (51)

1. Reiter RJ: Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991;12:151-180.
2. Waldhauser F, Waldhauser M, Lie-berman HR, Deng M-H, Lynch HJ, Wurtman RJ: Bioavailability of oral melatonin in humans. Neuroendocrinology 1984;39:307-313.
3. Arendt J: Melatonin. Clin Endocrinol (Oxf) 1988;29:205-229.
4. Fellenberg AJ, Phillipou G, Seamark RF: Specific quantitation of urinary 6-hydroxymelatonin sulphate by gas chromatography mass spectrometry. Biomed Mass Spec-trom 1980;7:84-87.
5. Matthews CD, Guerin MV, Wang X: Human plasma melatonin and urinary 6-sulphatoxy melatonin: Studies in natural annual photoperiod and in extended darkness. Clin Endocrinol (Oxf) 1991;35:21-27.
6. Baskett J, Cockrem J, Antunovich T: Sulphatoxymelatonin excretion in older people: Relationship to plasma melatonin and renal function. J Pineal Res 1998;24:58-61.
7. Borbely AA, Acherman P: Sleep regulation in humans. Conceptual advances and novel approaches; in Sleep and Sleep Disorders: From Molecule to Behavior. Tokyo, Academic Press, 1997, pp 147-161.
8. Akerstedt T, Gillberg M, Wetterberg L: The circadian covariance of fatigue and urinary melatonin. Biol Psychiatry 1982;17:547-554.
9. Lockley SW, Skene DJ, Tabandeh H, Bird AC, Defrance R, Arendt J: Relationship between napping and melatonin in the blind. J Biol Rhythms 1997;12:16-25.
10. Lavie P, Haimov I, Shochat T: Melatonin: Shutting off the wakefulness system; in Maestroni G, Conti A, Reiter R (eds): Therapeutic Potential of Melatonin. Front Horm Res. Basel, Karger, 1997, vol 23, pp 149-160.
11. Lewy AJ, Ahmed S, Jackson ML, Sack RL: Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992;9:380-392.
12. Dollins AB, Zhdanova IV, Wurt-man RJ, Lynch HJ, Deng MH: Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature and performance. Proc Nat Acad Sci USA 1994;91:1824-1828.
13. Folkard S, Arendt J, Aldhous M, Kennett H: Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms. Neurosci Lett 1990;113:193-198.
14. Samel A, Wegmann H-M, Vejvoda M, Maab H, Gundel A, Schutz M: Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shift. J Biol Rhythms 1991;6:235-248.
15. Samel A, Wegmann HM, Vejvvoda M: Jet lag and sleepiness in aircrew. J Sleep Res 1995;4:30-36.
16. Petrie K, Dawson AG, Thompson L, Brook R: A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry 1993;33:526-530.
17. Sack RL, Blood ML, Lewy AJ: Melatonin rhythms in night shift workers. Sleep 1992;15:434-441.
18. Folkard S, Arendt J, Clark M: Can melatonin improve shift workers’ tolerance of the night shift? Some preliminary findings. Chronobiol Int 1993;10:315-320.
19. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD: Delayed sleep phase syndrome response to melatonin. Lancet 1991; 337:1121-1124.
20. Oldani A, Ferini-Strambi L, Zuc-coni M, Stankov B, Fraschini F, Smirne S: Melatonin and delayed sleep phase syndrome: Ambulatory polygraphic evaluation. Neuroreport 1994;6:132-134.
21. Arendt J, Deacon S: Treatment of circadian rhythm disorders: Melatonin. Chronobiol Int 1997; 14:185-204.
22. Sack RL, Lewy AJ, Blood ML, Stevenson J, Donald Keith L: Melatonin administration to blind people: Phase advances and entrainment. J Biol Rhythms 1991;6:249-261.
23. Palm L, Blennow G, Wetterberg L: Correction of non-24-hour sleep-wake cycle by melatonin in a blind retarded boy. Ann Neurol 1991;29: 336-339.
24. Palm L, Blennow G, Wetterberg L: Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances. Dev Med Child Neurol 1997;39:319-325.
25. Tzischinsky O, Pal I, Epstein R, Da-gan Y, Lavie P: The importance of timing in melatonin administration in a blind man. J Pineal Res 1992; 12:105-108.
26. Nagtegaal E, Peeters T, Swart W, Smits M, Kerkhof G, van der Meer G: Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit 1998;20:181-183.
27. Shochat T, Luboshitzky R, Lavie P: Nocturnal melatonin onset is phase locked to the primary sleep gate. Am J Physiol 1997;273:R364-R370.
28. Dawson D, Encel N, Lushington K: Improving adaptation to simulated night shift: Timed exposure to bright light versus daytime melatonin administration. Sleep 1995; 18: 11-21.
29. Suhner A, Schlagenhauf P, Johnson R: Comparative study to determine the optimal melatonin dosage form for the alleviation of jet-lag. Int Cong Chronobiol, Paris, 1997.
30. Waldhauser F, Weiszenbacher G, Tatzer E, Geisinger B, Waldhauser M, Schemper M, Frisch H: Alterations in the nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988;66:648-652.
31. Arendt J: Melatonin and the Mammalian Pineal Gland. London, Chapman & Hall, 1995, pp 202.
32. Brugger P, Markti W, Harold M: Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995;345:1408.
33. Fiorina P, Lattuada G, Ponari O, Silvestrini C, Dall Aglio F: Impaired nocturnal melatonin excretion and changes in immunological status in ischemic stroke patients Lancet 1997;347:692.
34. Kabuto M, Namura I, Saitoh Y: Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans. Endocrinol Jpn 1986;33:405-414.
35. MacFarlane J, Cleghorn J, Brown G: Melatonin and core temperature rhythm in chronic insomnia. Adv Biosci 1984;53:303-306.
36. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky D: Sleep disorders and melatonin rhythms in elderly people. BMJ 1994;309:167.
37. Hajak G, Rodenbeck A, Staedt J, Bandelow B, Huether G, Ruther E: Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J Pineal Res 1996;19:116-122.
38. Rodenbeck A, Huether G, Hajak G: Sleep disorders and aging: Understanding the causes; in Touitou Y (ed): Biological Clocks. Mechanisms and Applications. Amsterdam, Elsevier, 1998, pp 329-332.
39. Pollak C, Perlick D, Linsner J: Daily sleep reports and circadian rest-activity cycles of elderly residents with insomnia. Biol Psychiatry 1992;32: 1019-1027.
40. Hughes RJ, Sack R, Lewy A: The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: Assessment in a clinical trial of melatonin replacement. Sleep 1998;21:52-68.
41. Kripke D, Elliot J, Youngstedt S, Smith J: Melatonin: Marvel or marker? Ann Med 1998;30:81-87.
42. Youngstedt SD, Kripke D, Elliott J: Melatonin excretion is not related to sleep in the elderly. J Pineal Res 1998;24:142-145.
43. Malik F, Mehra M, Ali A, Ventura O, Stapleton D, Brugger P, et al: Nocturnal melatonin release impairment and clinical effects of exogenous melatonin in chronic heart failure. J Am Coll Cardiol 1997;29 (suppl A):370A.
44. Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L: Melatonin secretion related to side-effects of P-blockers from the central nervous system. Acta Med Scand 1988;223: 525-530.
45. Lewy AJ, Siever LJ, Uhde TW, Mar-key SP: Clonidine reduces plasma melatonin levels. J Pharm Pharmacol 1986;38:555-556.
46. James SP, Sack DA, Rosenthal NE, Mendelson WB: Melatonin administration in insomnia. Neuropsychopharmacology 1990;3:19-23.
47. Ellis CM, Lemmens G, Parkes JD: Melatonin and insomnia. J Sleep Res 1996;5:61-65.
48. Haimov I, Lavie P, Laudon M, Her-er P, Vigder C, Zisapel N: Melatonin replacement therapy of elderly insomniacs. Sleep 1995;18:598.
49. Garfinkel D, Laudon M, Zisapel N: Improvement of sleep quality in elderly people by controlled release melatonin. Lancet 1995;346:541.
50. Garfinkel D, Laudon M, Zisapel N: Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch Gerontol Geriatr 1997; 24:223.
51. Wurtman R, Zhdanova I: Improvement of sleep quality by melatonin. Lancet 1995;346:1491.